{"gene":"FCGR2A","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1989,"finding":"FCGR2A (FcγRIIa/CD32A) encodes an integral membrane glycoprotein with two extracellular Ig-like domains, a single transmembrane domain, and a cytoplasmic domain distinct from FcγRIIb isoforms; expression of the cDNA in transfected cells produces IgG-binding molecules bearing CD32 epitopes, establishing it as a functional IgG receptor.","method":"cDNA cloning, sequencing, and transfection expression assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 — original structural/functional characterization by reconstitution in transfected cells, foundational paper","pmids":["2529342"],"is_preprint":false},{"year":1993,"finding":"The IgG Fc binding site of FcγRII (CD32) maps primarily to the second extracellular domain (D2γ), with epitopes defined by blocking mAbs all residing in D2γ and involving the IgG Fc binding region; domain 1 contributes to overall binding affinity.","method":"Chimeric receptor construction, mAb epitope mapping, EA rosette inhibition assays, flow cytometry on transfected cells","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods including chimeric receptors and functional blocking assays","pmids":["7679695"],"is_preprint":false},{"year":1994,"finding":"FcγRIIa (CD32A) is the sole IgG Fc receptor capable of binding human IgG2; the H131 allotype binds IgG2 with significantly higher affinity than the R131 allotype, and neutrophils homozygous for H/H131 mediate significantly greater phagocytosis of IgG2-opsonized bacteria than R/R131 neutrophils.","method":"Immunophenotyping, phagocytosis assays with IgG2-opsonized bacteria in neutrophils from genotyped donors","journal":"The Journal of infectious diseases","confidence":"High","confidence_rationale":"Tier 2 — functional phagocytosis assay directly linking allotype to IgG2 binding and bacterial killing, replicated across studies","pmids":["7930727","7930726"],"is_preprint":false},{"year":1994,"finding":"The H131/R131 polymorphism at amino acid 131 of FcγRIIa is determined by a single nucleotide difference (G or A) at base 494 encoding arginine or histidine, which dictates differential affinity for human IgG2.","method":"PCR amplification of genomic DNA and Southern analysis with allele-specific oligonucleotide probes","journal":"Journal of immunological methods","confidence":"High","confidence_rationale":"Tier 1 — direct genotyping method establishing molecular basis of the polymorphism","pmids":["8046255"],"is_preprint":false},{"year":1994,"finding":"FcγRIIa (CD32A) cross-linking on B lymphocytes triggers increases in intracellular Ca2+ ([Ca2+]i), whereas FcγRIIb isoforms do not; FcγRIIa efficiently internalizes IgG aggregates while FcγRIIb1 does not, demonstrating isoform-specific functional differences.","method":"Stable transfection of isoforms into mouse IIA1.6 B lymphoma cells, Ca2+ flux measurements, internalization assays, receptor capping assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in defined cell system with multiple functional readouts","pmids":["8283039"],"is_preprint":false},{"year":1995,"finding":"Multiple regions of FcγRII contribute to IgG binding: domain 1 contributes to affinity, and two segments of domain 2 (Ser109–Val116 and Ser130–Thr135, including residues Lys113, Pro114, Leu115, Val116, Phe129, and His131) are critical for IgG1 binding; substitution of Asp133 and Pro134 increases binding.","method":"Chimeric receptor construction between FcγRII and FcεRIα, site-directed mutagenesis, IgG binding assays, molecular modeling","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — chimeric receptor and site-directed mutagenesis with functional binding readout","pmids":["7673151"],"is_preprint":false},{"year":1995,"finding":"FcγRIIa signaling following cross-linking requires activation of Src-family tyrosine kinases and Syk, resulting in tyrosine phosphorylation of Shc and phospholipase Cγ isoforms and a cytosolic Ca2+ transient.","method":"Biochemical signaling assays, kinase inhibitor studies, immunoprecipitation","journal":"Seminars in immunology","confidence":"Medium","confidence_rationale":"Tier 2 — review summarizing direct experimental findings from signaling studies, single source","pmids":["7612894"],"is_preprint":false},{"year":1995,"finding":"The H131/R131 polymorphism at position 131 of FcγRIIa modulates binding of monoclonal IgG1 antibodies on platelets; the R131 form binds IgG1 mAbs with stronger affinity than H131, and differential platelet activation by mAbs correlates with the allotype-dependent binding affinity.","method":"Allotype-specific genotyping, IgG mAb binding assays on platelets from homozygous/heterozygous donors, platelet aggregation measurements","journal":"Thrombosis and haemostasis","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding and functional assays in human platelets with defined genotypes","pmids":["8772237"],"is_preprint":false},{"year":1996,"finding":"FcγRIIa (CD32A) cross-linking on dermal microvascular endothelial cells (DMEC) triggers immediate intracellular Ca2+ flux and rapid receptor internalization, demonstrating functional signaling capacity; DMEC express FcγRIIa (not FcγRIIb or FcγRIII) as determined by RT-PCR.","method":"Immunohistochemistry, RT-PCR, FACS, intracellular Ca2+ measurement, receptor internalization assay","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — direct functional assays with isoform-specific confirmation by RT-PCR","pmids":["8568259"],"is_preprint":false},{"year":1996,"finding":"FcγRIIa cross-linking in platelets leads to tyrosine phosphorylation and recruitment of Grb2-binding proteins (38 kDa and 63 kDa) in the particulate fraction; SH3 domains of Grb2 associate with SOS1, SLP-76 (75 kDa), and a 120 kDa protein, linking FcγRIIa to downstream Ras/SOS signaling.","method":"GST-Grb2 fusion protein pulldown, immunoprecipitation, SH2/SH3 domain binding assays, phosphoprotein identification by immunoblot","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — co-precipitation and domain-specific pulldown identifying signaling complex components","pmids":["8695800"],"is_preprint":false},{"year":1996,"finding":"Mac-1 (CD11b/CD18, αMβ2 integrin) but not p150,95 (CD11c/CD18) associates with FcγRIIA on K562 cells; anti-FcγRII mAbs inhibit Mac-1-mediated cell adhesion but not p150,95-mediated adhesion.","method":"Transfection of K562 cells with Mac-1 or p150,95, adhesion inhibition assays with anti-FcγRII mAbs","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 3 — functional association demonstrated by mAb inhibition without direct co-immunoprecipitation","pmids":["8566068"],"is_preprint":false},{"year":1998,"finding":"FcγRIIc (CD32) expression on NK cells is determined by an allelic polymorphism in the FcγRIIC gene first extracellular exon that generates either a functional open reading frame or a null allele; donors with the functional allele express CD32 capable of triggering NK-cell cytotoxicity, while null allele donors lack surface CD32 on NK cells.","method":"cDNA isolation and sequencing from NK cells, stable transfection, flow cytometry, cytotoxicity assays correlated with allele presence","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods including transfection and functional cytotoxicity assay","pmids":["9516136"],"is_preprint":false},{"year":1999,"finding":"FcγRIIa ligation on eosinophils in solution (soluble anti-CD32 mAb or cross-linked IgG) promotes survival by inducing autocrine GM-CSF production, whereas immobilized anti-CD32 mAb or IgG triggers eosinophil apoptosis dependent on β2 integrin engagement.","method":"In vitro eosinophil culture with anti-CD32 mAbs in solution vs. immobilized, apoptosis detection (DNA fragmentation, Annexin-V), anti-GM-CSF blocking, anti-CD18 blocking","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic dissection with blocking antibodies and multiple readouts","pmids":["10201955"],"is_preprint":false},{"year":1999,"finding":"Biochemical characterization established that FcγRIIa binds IgG3 (KD = 0.6 μM) and also IgG4 (KD = 3 μM), extending its known ligand repertoire; both N-linked glycosylation sites on FcγRIIa are occupied.","method":"Equilibrium binding analysis of recombinant FcγRIIa with IgG subclasses, electrospray ionization mass spectrometry for glycan characterization, crystallization yielding diffraction-quality crystals at 2.1 Å","journal":"Immunology letters","confidence":"High","confidence_rationale":"Tier 1 — in vitro binding assay with recombinant protein and structural crystallization","pmids":["10397151"],"is_preprint":false},{"year":2000,"finding":"In resting neutrophils, FcγRIIa (CD32A) is maintained in a low-affinity state for IgG binding; activation with fMLP converts CD32A to a high-affinity state without increasing surface expression, enabling CD32A-dependent immune complex binding and phagocytosis. This affinity modulation was not observed in CHO cells expressing CD32A, indicating a cell-specific mechanism.","method":"Use of CD16B-deficient donor neutrophils and anti-CD16 blocking mAbs, fMLP activation, IgG-opsonized erythrocyte rosetting assays, immune complex binding assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — natural genetic deficiency model combined with activation assays and CHO cell controls demonstrating cell-specificity","pmids":["10648424"],"is_preprint":false},{"year":2000,"finding":"CD32 cross-linking in platelets rapidly induces tyrosine phosphorylation and activation of Bruton's tyrosine kinase (Btk) and Tec kinase via a mechanism involving Src family kinases and PI3K through ITAM-mediated recruitment.","method":"CD32 cross-linking in human platelets (including XLA patient platelets), immunoprecipitation, phosphopeptide-specific antibodies against Btk regulatory residues, kinase inhibitor studies","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — direct biochemical and pharmacological dissection of kinase activation downstream of CD32","pmids":["10688822"],"is_preprint":false},{"year":2001,"finding":"The cytoplasmic tail of FcγRIIa is required for phagolysosome fusion: wild-type FcγRIIa-mediated phagosomes fuse with lysosomes, but a tail-minus FcγRIIa (even when phagocytosis is rescued by complement receptor CR3) fails to support phagolysosome fusion. This function does not require a functional ITAM sequence.","method":"Genetic complementation using tail-minus and ITAM-mutant FcγRIIa, fluorescent dextran lysosome labeling, colocalization microscopy, electron microscopy with acid phosphatase detection","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with reconstitution and multiple imaging methods establishing cytoplasmic tail requirement for a specific downstream function","pmids":["11719384"],"is_preprint":false},{"year":2001,"finding":"SAM68 (68 kDa Src-associated protein) is present in human neutrophils, becomes tyrosine-phosphorylated following CD32 ligation, and its association with poly-U RNA decreases upon CD32 stimulation, implicating SAM68 in post-transcriptional regulation downstream of FcγRIIa.","method":"Immunoprecipitation, tyrosine phosphorylation assays, poly-U Sepharose pulldown assays after CD32 cross-linking","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, single method type, mechanistic follow-up partial","pmids":["11254726"],"is_preprint":false},{"year":2003,"finding":"Cross-linking of FcγRII (CD32) with immobilized IgG induces maturation of human monocyte-derived dendritic cells via the NF-κB signaling pathway, accompanied by moderate IL-10 (but not IL-12) secretion and enhanced allogeneic T cell proliferation; this is blocked by anti-CD32 mAb.","method":"Cross-linking with immobilized IgG, NF-κB activation assays, cytokine ELISA, allogeneic T cell proliferation assay, anti-CD32 mAb blocking","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — receptor-specific blocking with defined pathway readout","pmids":["12682223"],"is_preprint":false},{"year":2003,"finding":"The cytoplasmic L-T-L motif of FcγRIIa controls the spatiotemporal routing of calcium waves to phagosomes: mutation of this motif prevents calcium signal routing to the phagosome and abrogates phagolysosome fusion, despite normal recruitment of lysosome-associated proteins Rab5 and Rab7.","method":"High-speed calcium imaging of live cells, mutagenesis of cytoplasmic L-T-L motif, immunofluorescence for Rab5, Rab7, and LAMP-1","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 1 — site-directed mutagenesis with live-cell functional imaging and multiple controls identifying specific cytoplasmic sequence","pmids":["12676989"],"is_preprint":false},{"year":2004,"finding":"Cross-linking of CD32A in neutrophil plasma membranes causes its recruitment to high-density flotillin-1-positive detergent-resistant membrane (DRM) microdomains prior to tyrosine phosphorylation; Src kinases and Syk are constitutively present in DRMs and tyrosine phosphorylation of CD32A and Syk is inhibited by the Src kinase inhibitor PP2 and by methyl-β-cyclodextrin.","method":"Purified neutrophil plasma membranes, DRM fractionation, immunoblotting, Src kinase inhibitor PP2, methyl-β-cyclodextrin cholesterol depletion","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical fractionation with pharmacological inhibitors in defined membrane system","pmids":["15130090"],"is_preprint":false},{"year":2005,"finding":"DNA-containing immune complexes from lupus serum activate plasmacytoid DCs via cooperative interaction between FcγRIIa (CD32) and TLR9: CD32 internalizes SLE immune complexes into a subcellular compartment co-containing TLR9, and only CD32+ PDCs (not CD32- PDCs) respond to SLE-ICs, defining a pathway where CD32 delivers immune complexes to lysosomal TLR9.","method":"Colocalization microscopy, sorting of CD32+ vs CD32- PDCs, cytokine/chemokine production assays, blocking with anti-CD32","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including sorting, colocalization, and functional cytokine assays, highly cited","pmids":["15668740"],"is_preprint":false},{"year":2006,"finding":"FcγRIIA (CD32) mediates enhanced dengue virus immune complex infectivity more effectively than FcγRIA; abrogation of FcγRIIA ITAM signaling by tyrosine-to-phenylalanine mutagenesis impairs phagocytosis equally but does not impair dengue virus immune complex infectivity, revealing a signaling-independent mechanism of viral internalization via FcγRIIA.","method":"Site-directed mutagenesis of ITAM tyrosines, transfection into COS-7 cells, dengue virus replication assays (plaque assay and flow cytometry)","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with reconstitution in defined cell system distinguishing phagocytosis from viral entry","pmids":["17005690"],"is_preprint":false},{"year":2007,"finding":"Antiendothelial cell antibodies (AECAs) bound to endothelial cells enhance PMN adhesion through FcγRIIa in an E-selectin-, CXCR1/2-, and β2-integrin-dependent mechanism requiring cooperation between FcγRIIa and CXCR1/2; this mechanism is distinct from immune complex-mediated FcγRIIIb-dependent PMN adhesion.","method":"Adenoviral transduction of endothelial cells, neutralizing antibodies to E-selectin/CXCR1/2/β2-integrins, anti-FcγRIIa blocking, pertussis toxin inhibition, AECA IgG from SLE patients","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple blocking antibodies and genetic approaches defining cooperative mechanism with distinct pathway readout","pmids":["17244681"],"is_preprint":false},{"year":2007,"finding":"CD300a (IRp60), an ITIM-containing inhibitory receptor, colligates with FcγRIIa (CD32A) on neutrophils to inhibit CD32A-mediated signaling but not TLR4-mediated ROS production, demonstrating selective inhibitory control of FcγRIIa-dependent responses.","method":"Co-ligation experiments with anti-CD300a and anti-CD32A in neutrophils, ROS production assays, signaling inhibition assays","journal":"Molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2 — co-ligation functional assay with specificity control (TLR4 not affected)","pmids":["17588661"],"is_preprint":false},{"year":2008,"finding":"Bevacizumab immune complexes (with VEGF) activate platelets via FcγRIIa and cause thrombosis in FcγRIIa transgenic mice; VEGF's heparin-binding domain is required, and heparin promotes Bev IC deposition on platelets in a mechanism resembling heparin-induced thrombocytopenia.","method":"In vitro platelet activation assays, FcγRIIa transgenic mice thrombosis model, aglycosylated antibody controls, heparin-binding domain analysis","journal":"Journal of thrombosis and haemostasis","confidence":"High","confidence_rationale":"Tier 2 — in vitro and in vivo assays with mechanistic controls including aglycosylated antibody and domain-specific requirements","pmids":["18983497"],"is_preprint":false},{"year":2008,"finding":"IVIg and CMVIg induce CD32-dependent platelet aggregation in vitro; the aggregation is completely abrogated by an anti-CD32 blocking antibody (AT10), demonstrating that activating Fc domains in immunoglobulin preparations directly engage platelet FcγRIIa to trigger aggregation.","method":"In vitro aggregometry with platelet concentrates, anti-CD32 mAb (AT10) blocking, CD62P expression by FACS, sCD40L ELISA","journal":"The British journal of dermatology","confidence":"Medium","confidence_rationale":"Tier 2 — receptor-specific blocking with multiple platelet activation readouts","pmids":["18565176"],"is_preprint":false},{"year":2009,"finding":"FcγRIIa (CD32A) association with lipid raft microdomains regulates its IgG binding activity: cholesterol depletion or sequestration inhibits CD32A-mediated IgG binding; CD32A mutants with reduced lipid raft association (A224S and C241A) show decreased IgG binding; GPI-anchored (constitutively raft-associated) CD32A displays increased IgG binding capacity.","method":"Cholesterol depletion/sequestration, site-directed mutagenesis of CD32A (A224S, C241A), GPI-anchored CD32A construct, IgG binding assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with pharmacological manipulation and GPI-anchor reconstitution with functional binding readout","pmids":["19494328"],"is_preprint":false},{"year":2009,"finding":"The R allele of CD32A has significantly lower binding affinity not only to IgG2 but also to IgG1 and IgG3 compared with the H allele; CD32A(H)-Ig outcompetes CD32A(R)-Ig for immune complex binding, whereas CD32A(R)-Ig cannot cross-block CD32A(H) binding, as shown by 2D affinity measurements.","method":"Ig fusion proteins of CD32A alleles, competition binding assays, 2D affinity measurements, cell surface CD32A blocking studies","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — in vitro binding assays with purified allelic proteins and 2D affinity measurements","pmids":["20007585"],"is_preprint":false},{"year":2010,"finding":"Anti-CD40L immune complex-induced thrombosis is FcγRIIa-dependent: anti-CD40L ICs cause shock, thrombocytopenia, and pulmonary thrombi in FCGR2A transgenic mice but not wild-type mice; aglycosylated antibody (which cannot bind FcγRIIa) fails to cause these effects.","method":"FCGR2A transgenic mouse model, i.v. injection of preformed ICs, aglycosylated antibody control, thrombin inhibitor pretreatment, histopathology of pulmonary thrombi","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — in vivo transgenic model with aglycosylated antibody control establishing FcγRIIa requirement","pmids":["20585032"],"is_preprint":false},{"year":2011,"finding":"CRP-derived peptide 201–206 inhibits neutrophil adhesion to endothelial cells and platelet-mediated neutrophil capture via CD32 (FcγRII); anti-CD32 but not anti-CD16 or anti-CD64 mAb blocks these inhibitory actions; specific residues Lys201, Gln203, and Trp205 are required for peptide-CD32 interaction.","method":"Anti-CD32/CD16/CD64 mAb blocking of peptide effects, alanine-substitution peptide analogues, neutrophil adhesion under shear flow, platelet P-selectin assays","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 — receptor-specific blocking and structure-activity analysis identifying key residues","pmids":["21934067"],"is_preprint":false},{"year":2017,"finding":"CRP binds surface CD32 (FcγRII) on myeloma cells and activates a p38 MAPK–Twist signaling pathway that enhances secretion of osteolytic cytokines and promotes osteoclastogenesis and bone destruction in vivo.","method":"CRP-CD32 binding assays, p38 MAPK activation and Twist pathway analysis, in vivo human bone graft/myeloma xenograft model, cytokine secretion assays","journal":"Science signaling","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro pathway analysis and in vivo model establishing ligand-receptor-pathway-phenotype link","pmids":["29233917"],"is_preprint":false},{"year":2018,"finding":"FcγRIIA/CD32A-expressing platelets are directly activated by IgG immune complexes in vivo and are critical determinants of IgG-dependent anaphylaxis severity: platelet depletion attenuates anaphylaxis, thrombocythemia worsens it, and serotonin released by activated platelets contributes to severity. FcγRIIA-expressing platelets are sufficient to restore anaphylaxis susceptibility in resistant mice.","method":"Human FcγRIIA-expressing mouse models, platelet depletion, thrombocythemia induction, platelet activation by IgG ICs in vivo, serotonin blockade, patient cohort correlation","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple in vivo genetic models with sufficiency/necessity testing and mechanistic mediator identification","pmids":["29654057"],"is_preprint":false},{"year":2019,"finding":"BTK is a key downstream mediator of FcγRIIA (CD32a)-induced platelet activation; BTK inhibitors (ibrutinib, acalabrutinib, zanubrutinib, tirabrutinib, evobrutinib, fenebrutinib) potently block FcγRIIA cross-linking-induced platelet aggregation, secretion, P-selectin expression, and platelet-neutrophil complex formation at clinically relevant concentrations.","method":"FcγRIIA cross-linking in human blood, aggregometry with BTK inhibitors at defined IC50 values, P-selectin FACS, ATP secretion assays, HIT patient sera stimulation, single oral dose pharmacodynamics in volunteers","journal":"Blood advances","confidence":"High","confidence_rationale":"Tier 2 — multiple BTK inhibitors with consistent IC50 values, multiple platelet activation readouts, and ex vivo clinical validation","pmids":["31809536"],"is_preprint":false},{"year":2020,"finding":"FcRn acts as a coreceptor for CD32a (FcγRIIa): CD32aH (H131 variant) more avidly binds human IgG1 immune complexes than CD32aR and forms a ternary complex with FcRn under acidic conditions; both CD32a variants require FcRn to induce innate and adaptive immune responses to IgG1 ICs, with responses augmented for CD32aH. FcRn blockade reduced inflammation in an arthritis model without lowering circulating autoantibody levels.","method":"Binding assays (CD32aH vs CD32aR with IgG1 IC), ternary complex formation assays under acidic pH, primary human and mouse cell functional assays, FcRn knockout/blockade, rheumatoid arthritis model","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including biochemical complex formation, primary cell assays, in vivo model with genetic and pharmacological FcRn manipulation","pmids":["32658257"],"is_preprint":false},{"year":2020,"finding":"SRF231, a human IgG4 anti-CD47 antibody, exerts antitumor activity via dual engagement of macrophage-derived CD32a: its Fc domain engages CD32a to drive FcγR-mediated phagocytosis of cancer cells and acts as a scaffold to drive CD47-mediated death signaling into tumor cells; both mechanisms are CD32a-dependent.","method":"In vitro macrophage:tumor cell co-culture, FcγR blocking, macrophage depletion, xenograft mouse models, cytokine analysis","journal":"Journal for immunotherapy of cancer","confidence":"Medium","confidence_rationale":"Tier 2 — receptor-specific blocking and macrophage depletion with mechanistic dissection in vitro and in vivo","pmids":["32345627"],"is_preprint":false}],"current_model":"FcγRIIa (FCGR2A/CD32A) is a single-transmembrane activating IgG Fc receptor whose second extracellular domain (particularly residues around His131) mediates IgG binding with allotype-dependent affinity (H131 > R131 for IgG1/2/3), whose ITAM-containing cytoplasmic tail recruits Src-family kinases and Syk to trigger Ca2+ flux, Btk/Tec activation, and downstream signaling; association with lipid rafts regulates its IgG-binding affinity, while an L-T-L cytoplasmic motif routes Ca2+ signals to phagosomes enabling phagolysosome fusion; on platelets and myeloid cells FcγRIIa transduces IgG immune complex signals through Syk and BTK to mediate phagocytosis, ADCC, anaphylaxis, and thrombosis, and cooperates with FcRn as a coreceptor and with TLR9 (via immune complex internalization) and with inhibitory receptors such as CD300a and FcγRIIb to fine-tune immune activation."},"narrative":{"teleology":[{"year":1989,"claim":"Molecular cloning established FCGR2A as a gene encoding a distinct activating IgG receptor isoform with two Ig-like extracellular domains, a transmembrane segment, and a unique cytoplasmic tail, resolving the molecular identity of the CD32A isoform.","evidence":"cDNA cloning, sequencing, and transfection expression in heterologous cells","pmids":["2529342"],"confidence":"High","gaps":["Full domain architecture and 3D structure not yet determined","Signaling mechanism of cytoplasmic tail unknown"]},{"year":1994,"claim":"Identification of the H131/R131 single-nucleotide polymorphism as the molecular basis for differential IgG subclass binding — particularly unique IgG2 recognition by the H131 variant — answered how genetic variation in a single receptor controls subclass-specific immunity and susceptibility to encapsulated bacterial infections.","evidence":"Genotyping by allele-specific oligonucleotides combined with phagocytosis assays of IgG2-opsonized bacteria in neutrophils from defined donors","pmids":["7930727","7930726","8046255"],"confidence":"High","gaps":["Structural basis of how position 131 alters IgG2 contact not resolved","Clinical impact on infection outcomes required prospective studies"]},{"year":1995,"claim":"Domain mapping and mutagenesis pinpointed the IgG-binding interface to two segments in extracellular domain 2 (Ser109–Val116 and Ser130–Thr135) while showing domain 1 contributes to overall affinity, defining the ligand-recognition architecture at residue-level resolution.","evidence":"Chimeric FcγRII/FcεRIα receptors, site-directed mutagenesis, and IgG binding assays","pmids":["7673151","7679695"],"confidence":"High","gaps":["Co-crystal structure with IgG Fc not yet available","Contribution of glycosylation to binding affinity unclear"]},{"year":1995,"claim":"Biochemical dissection of the signaling cascade revealed that FcγRIIa cross-linking activates Src-family kinases and Syk, leading to PLCγ phosphorylation, Shc recruitment, and Ca²⁺ flux — establishing the ITAM-dependent proximal signaling pathway distinct from the inhibitory FcγRIIb isoform.","evidence":"Kinase inhibitor studies, immunoprecipitation, Ca²⁺ measurements in transfected B cells and primary cells","pmids":["7612894","8283039"],"confidence":"Medium","gaps":["Relative contribution of individual Src-family members not determined","Signaling requirement for phagocytosis vs. other effector functions not separated"]},{"year":2000,"claim":"Discovery that neutrophil activation (fMLP) converts surface FcγRIIa from a low- to high-affinity IgG-binding state without changing expression levels revealed an inside-out affinity regulation mechanism, explaining how resting cells avoid spurious immune complex engagement.","evidence":"IgG-opsonized erythrocyte rosetting with CD16B-deficient donor neutrophils vs. CHO cells expressing CD32A","pmids":["10648424"],"confidence":"High","gaps":["Molecular mechanism of affinity switch (conformational change, lateral partner, or lipid environment) not defined","Whether affinity modulation operates in other cell types unknown"]},{"year":2003,"claim":"Identification of the cytoplasmic L-T-L motif as the element routing Ca²⁺ signals to nascent phagosomes and enabling phagolysosome fusion — independent of the ITAM — resolved how FcγRIIa couples ligand engagement to microbicidal phagosome maturation beyond simple internalization.","evidence":"Site-directed mutagenesis of L-T-L motif, high-speed Ca²⁺ imaging, lysosomal colocalization microscopy","pmids":["12676989","11719384"],"confidence":"High","gaps":["Direct binding partner of the L-T-L motif not identified","Whether L-T-L motif regulates Ca²⁺ channel recruitment or release from stores unclear"]},{"year":2005,"claim":"Demonstration that FcγRIIa internalizes DNA-containing immune complexes into TLR9-positive endosomal compartments of plasmacytoid dendritic cells established a cooperative FcγRIIa–TLR9 pathway linking adaptive IgG responses to innate nucleic acid sensing, with direct relevance to lupus pathogenesis.","evidence":"Sorting of CD32+ vs. CD32− PDCs, colocalization microscopy, anti-CD32 blocking, cytokine production assays","pmids":["15668740"],"confidence":"High","gaps":["Whether other FcγRs can substitute for CD32A in this pathway not tested","Mechanism of immune complex routing to TLR9-containing compartment not defined"]},{"year":2009,"claim":"Mutagenesis and cholesterol manipulation showed that lipid-raft association regulates FcγRIIa IgG-binding capacity — with raft-excluded mutants binding less IgG and GPI-anchored (constitutively raft-associated) CD32A binding more — providing a membrane-organizational mechanism for affinity modulation.","evidence":"A224S and C241A mutants, GPI-anchored CD32A, cholesterol depletion/sequestration, IgG binding assays","pmids":["19494328"],"confidence":"High","gaps":["Relationship between raft association and inside-out activation (fMLP effect) not integrated","Whether raft partitioning changes receptor oligomerization state unknown"]},{"year":2009,"claim":"Quantitative 2D affinity measurements extended the allotype-dependent binding hierarchy to all tested IgG subclasses — H131 outcompetes R131 for IgG1, IgG2, and IgG3 — refining the functional impact of the polymorphism beyond the IgG2-centric view.","evidence":"Ig fusion proteins of both CD32A alleles, competition binding and 2D affinity assays","pmids":["20007585"],"confidence":"High","gaps":["Absolute 3D KD values for each allotype–subclass pair not all determined","Functional consequences for IgG4 binding by each allotype not measured"]},{"year":2010,"claim":"In vivo demonstration that FcγRIIa on platelets is necessary and sufficient for immune complex–induced thrombosis — using transgenic mice, aglycosylated antibody controls, and thrombin inhibition — established the receptor as the key mediator of antibody-triggered thrombotic events such as heparin-induced thrombocytopenia.","evidence":"FCGR2A transgenic mouse thrombosis models with anti-CD40L and bevacizumab immune complexes, aglycosylated antibody controls","pmids":["20585032","18983497"],"confidence":"High","gaps":["Relative contribution of platelet serotonin vs. thrombin generation not fully delineated","Whether FcγRIIa signaling in thrombosis requires the same ITAM–Syk axis as phagocytosis not proven"]},{"year":2018,"claim":"FcγRIIa-expressing platelets were shown to be critical determinants of IgG-dependent anaphylaxis severity in vivo: platelet depletion attenuated anaphylaxis, thrombocythemia exacerbated it, and serotonin released by activated platelets was identified as a key mediator, establishing a platelet–FcγRIIa–serotonin axis in systemic anaphylaxis.","evidence":"Human FCGR2A transgenic mice, platelet depletion/expansion, serotonin blockade, patient cohort correlation","pmids":["29654057"],"confidence":"High","gaps":["Relative importance of platelet vs. myeloid FcγRIIa in human anaphylaxis not resolved","Downstream signaling from FcγRIIa to serotonin release machinery not mapped"]},{"year":2019,"claim":"Pharmacological profiling with six distinct BTK inhibitors demonstrated that BTK is the critical kinase downstream of FcγRIIa cross-linking for platelet aggregation, secretion, and platelet–neutrophil complex formation, validating BTK as a druggable node in FcγRIIa-driven thromboinflammation.","evidence":"Multiple BTK inhibitors at defined IC50 values, aggregometry, P-selectin FACS, ATP secretion, HIT sera, single-dose pharmacodynamics in volunteers","pmids":["31809536"],"confidence":"High","gaps":["Whether BTK inhibition also blocks FcγRIIa-driven phagocytosis in myeloid cells with equal potency not shown","Compensatory kinase pathways in platelet FcγRIIa signaling not explored"]},{"year":2020,"claim":"Identification of FcRn as a coreceptor that forms a ternary complex with FcγRIIa and IgG1 immune complexes under acidic endosomal conditions revealed an unanticipated cooperative mechanism by which two Fc receptors jointly amplify innate and adaptive immune responses to IgG ICs.","evidence":"Biochemical ternary complex assays at acidic pH, FcRn knockout/blockade, primary human and mouse cell functional assays, arthritis model","pmids":["32658257"],"confidence":"High","gaps":["Whether FcRn cooperates with FcγRIIa for all IgG subclasses not tested","Structural basis of the ternary complex unknown","Whether FcRn coreceptor function extends to FcγRIIa-mediated phagocytosis not demonstrated"]},{"year":null,"claim":"Key unresolved questions include the structural basis of inside-out affinity regulation, the identity of the direct cytoplasmic binding partner of the L-T-L motif that routes Ca²⁺ to phagosomes, whether the FcRn–FcγRIIa coreceptor axis operates across all IgG subclasses and cell types, and how FcγRIIa signaling differentially programs cell-type-specific outcomes (phagocytosis, thrombosis, anaphylaxis, DC maturation).","evidence":"","pmids":[],"confidence":"Low","gaps":["Structural basis of inside-out affinity modulation unknown","L-T-L motif binding partner unidentified","Cell-type-specific signaling wiring downstream of common ITAM not mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,4,6,15]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[24,34]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,14,20,27]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[21,34]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[16,19]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,4,6,18,21,32,34]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,9,15,20,31,33]},{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[25,26,29,32]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[12]}],"complexes":[],"partners":["SYK","BTK","TEC","FCGRT","TLR9","CD300A","ITGAM","KHDRBS1"],"other_free_text":[]},"mechanistic_narrative":"FCGR2A (FcγRIIa/CD32A) is a low-affinity activating IgG Fc receptor expressed on myeloid cells, platelets, and endothelial cells that transduces immune complex signals to drive phagocytosis, platelet activation, dendritic cell maturation, and anaphylaxis. Its two extracellular Ig-like domains bind all four human IgG subclasses, with the second domain (D2) harboring critical contact residues including the H131/R131 polymorphism that governs allotype-dependent affinity — the H131 variant uniquely confers efficient IgG2 binding and generally higher affinity for IgG1 and IgG3 [PMID:7930727, PMID:20007585]. Cross-linking triggers ITAM-dependent recruitment of Src-family kinases and Syk, activation of Btk/Tec kinases, PLCγ phosphorylation, and Ca²⁺ flux, while lipid-raft association regulates IgG-binding capacity and a cytoplasmic L-T-L motif routes calcium signals to phagosomes to enable phagolysosome fusion [PMID:7612894, PMID:19494328, PMID:12676989, PMID:31809536]. Beyond classical ITAM signaling, FcγRIIa cooperates with FcRn as a coreceptor for IgG1 immune complex responses, delivers DNA-containing immune complexes to TLR9 in plasmacytoid dendritic cells, and on platelets is the critical receptor mediating IgG immune complex–driven thrombosis and IgG-dependent anaphylaxis [PMID:32658257, PMID:15668740, PMID:29654057, PMID:20585032]."},"prefetch_data":{"uniprot":{"accession":"P12318","full_name":"Low affinity immunoglobulin gamma Fc region receptor II-a","aliases":["CDw32","Fc-gamma RII-a","Fc-gamma-RIIa","FcRII-a"],"length_aa":317,"mass_kda":35.0,"function":"Binds to the Fc region of immunoglobulins gamma. Low affinity receptor. By binding to IgG it initiates cellular responses against pathogens and soluble antigens. Promotes phagocytosis of opsonized antigens","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P12318/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FCGR2A","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FCGR2A","total_profiled":1310},"omim":[{"mim_id":"612169","title":"Fc FRAGMENT OF IgG RECEPTOR IIc; FCGR2C","url":"https://www.omim.org/entry/612169"},{"mim_id":"611775","title":"KAWASAKI DISEASE","url":"https://www.omim.org/entry/611775"},{"mim_id":"611162","title":"MALARIA, SUSCEPTIBILITY TO","url":"https://www.omim.org/entry/611162"},{"mim_id":"610665","title":"Fc FRAGMENT OF IgG RECEPTOR IIIb; FCGR3B","url":"https://www.omim.org/entry/610665"},{"mim_id":"610307","title":"CERAMIDE KINASE; CERK","url":"https://www.omim.org/entry/610307"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Golgi apparatus","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":113.4},{"tissue":"placenta","ntpm":126.7}],"url":"https://www.proteinatlas.org/search/FCGR2A"},"hgnc":{"alias_symbol":["CD32","CD32A","IGFR2","CDw32","Fc-gamma-RIIa","FcgammaRIIa"],"prev_symbol":["FCG2","FCGR2A1","FCGR2"]},"alphafold":{"accession":"P12318","domains":[{"cath_id":"2.60.40.10","chopping":"39-122","consensus_level":"medium","plddt":92.5546,"start":39,"end":122},{"cath_id":"2.60.40.10","chopping":"123-209","consensus_level":"medium","plddt":96.9737,"start":123,"end":209}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P12318","model_url":"https://alphafold.ebi.ac.uk/files/AF-P12318-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P12318-F1-predicted_aligned_error_v6.png","plddt_mean":76.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FCGR2A","jax_strain_url":"https://www.jax.org/strain/search?query=FCGR2A"},"sequence":{"accession":"P12318","fasta_url":"https://rest.uniprot.org/uniprotkb/P12318.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P12318/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P12318"}},"corpus_meta":[{"pmid":"15668740","id":"PMC_15668740","title":"Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.","date":"2005","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/15668740","citation_count":666,"is_preprint":false},{"pmid":"17704420","id":"PMC_17704420","title":"FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.","date":"2007","source":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17704420","citation_count":383,"is_preprint":false},{"pmid":"2529342","id":"PMC_2529342","title":"Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes.","date":"1989","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2529342","citation_count":308,"is_preprint":false},{"pmid":"22081228","id":"PMC_22081228","title":"Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.","date":"2011","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22081228","citation_count":280,"is_preprint":false},{"pmid":"28297712","id":"PMC_28297712","title":"CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28297712","citation_count":193,"is_preprint":false},{"pmid":"8849356","id":"PMC_8849356","title":"Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients.","date":"1995","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/8849356","citation_count":171,"is_preprint":false},{"pmid":"7930726","id":"PMC_7930726","title":"Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children.","date":"1994","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/7930726","citation_count":157,"is_preprint":false},{"pmid":"7930727","id":"PMC_7930727","title":"Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections.","date":"1994","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/7930727","citation_count":145,"is_preprint":false},{"pmid":"20585032","id":"PMC_20585032","title":"Anti-CD40L immune complexes potently activate platelets in vitro and cause thrombosis in FCGR2A transgenic mice.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20585032","citation_count":139,"is_preprint":false},{"pmid":"18983497","id":"PMC_18983497","title":"Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice.","date":"2008","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/18983497","citation_count":134,"is_preprint":false},{"pmid":"19309690","id":"PMC_19309690","title":"Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B.","date":"2009","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/19309690","citation_count":131,"is_preprint":false},{"pmid":"8046255","id":"PMC_8046255","title":"Ethnic variation in frequency of an allelic polymorphism of human Fc gamma RIIA determined with allele specific oligonucleotide probes.","date":"1994","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/8046255","citation_count":126,"is_preprint":false},{"pmid":"30941127","id":"PMC_30941127","title":"The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30941127","citation_count":117,"is_preprint":false},{"pmid":"17386079","id":"PMC_17386079","title":"Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization.","date":"2007","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17386079","citation_count":115,"is_preprint":false},{"pmid":"8283039","id":"PMC_8283039","title":"Functional analysis of human Fc gamma RII (CD32) isoforms expressed in B lymphocytes.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8283039","citation_count":113,"is_preprint":false},{"pmid":"17005690","id":"PMC_17005690","title":"Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32).","date":"2006","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/17005690","citation_count":103,"is_preprint":false},{"pmid":"9516136","id":"PMC_9516136","title":"Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene.","date":"1998","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9516136","citation_count":97,"is_preprint":false},{"pmid":"27812689","id":"PMC_27812689","title":"Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial.","date":"2017","source":"JAMA oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27812689","citation_count":91,"is_preprint":false},{"pmid":"16682723","id":"PMC_16682723","title":"FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor.","date":"2006","source":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16682723","citation_count":88,"is_preprint":false},{"pmid":"29669853","id":"PMC_29669853","title":"CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.","date":"2018","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29669853","citation_count":88,"is_preprint":false},{"pmid":"10688822","id":"PMC_10688822","title":"Rapid tyrosine phosphorylation and activation of Bruton's tyrosine/Tec kinases in platelets induced by collagen binding or CD32 cross-linking.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10688822","citation_count":82,"is_preprint":false},{"pmid":"7612894","id":"PMC_7612894","title":"Function of human Fc gamma RIIA and Fc gamma RIIIB.","date":"1995","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7612894","citation_count":77,"is_preprint":false},{"pmid":"14740869","id":"PMC_14740869","title":"Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa.","date":"2003","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/14740869","citation_count":74,"is_preprint":false},{"pmid":"29654057","id":"PMC_29654057","title":"Platelets expressing IgG receptor FcγRIIA/CD32A determine the severity of experimental anaphylaxis.","date":"2018","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29654057","citation_count":65,"is_preprint":false},{"pmid":"17588661","id":"PMC_17588661","title":"The CD300a (IRp60) inhibitory receptor is rapidly up-regulated on human neutrophils in response to inflammatory stimuli and modulates CD32a (FcgammaRIIa) mediated signaling.","date":"2007","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17588661","citation_count":65,"is_preprint":false},{"pmid":"11398118","id":"PMC_11398118","title":"Fcgamma receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project.","date":"2001","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/11398118","citation_count":64,"is_preprint":false},{"pmid":"7679695","id":"PMC_7679695","title":"Mapping epitopes of human Fc gamma RII (CDw32) with monoclonal antibodies and recombinant receptors.","date":"1993","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7679695","citation_count":60,"is_preprint":false},{"pmid":"30013105","id":"PMC_30013105","title":"CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30013105","citation_count":60,"is_preprint":false},{"pmid":"15217834","id":"PMC_15217834","title":"FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15217834","citation_count":59,"is_preprint":false},{"pmid":"7673151","id":"PMC_7673151","title":"Multiple regions of human Fc gamma RII (CD32) contribute to the binding of IgG.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7673151","citation_count":56,"is_preprint":false},{"pmid":"8568259","id":"PMC_8568259","title":"Dermal microvascular endothelial cells express CD32 receptors in vivo and in vitro.","date":"1996","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8568259","citation_count":53,"is_preprint":false},{"pmid":"10648424","id":"PMC_10648424","title":"Cell-specific, activation-dependent regulation of neutrophil CD32A ligand-binding function.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10648424","citation_count":52,"is_preprint":false},{"pmid":"2138195","id":"PMC_2138195","title":"Different isoforms of human FcRII distinguished by CDw32 antibodies.","date":"1990","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2138195","citation_count":49,"is_preprint":false},{"pmid":"27999754","id":"PMC_27999754","title":"Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD2 antibody ch14.18/CHO show higher ADCC levels and improved event-free survival.","date":"2016","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/27999754","citation_count":48,"is_preprint":false},{"pmid":"31809536","id":"PMC_31809536","title":"Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?","date":"2019","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/31809536","citation_count":48,"is_preprint":false},{"pmid":"32345627","id":"PMC_32345627","title":"The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a.","date":"2020","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32345627","citation_count":47,"is_preprint":false},{"pmid":"12682223","id":"PMC_12682223","title":"Cross-linking of CD32 induces maturation of human monocyte-derived dendritic cells via NF-kappa B signaling pathway.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12682223","citation_count":47,"is_preprint":false},{"pmid":"9496155","id":"PMC_9496155","title":"Fc gamma RIIa polymorphism in systemic lupus erythematosus.","date":"1997","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/9496155","citation_count":47,"is_preprint":false},{"pmid":"22885164","id":"PMC_22885164","title":"Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22885164","citation_count":46,"is_preprint":false},{"pmid":"16846526","id":"PMC_16846526","title":"Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis.","date":"2006","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/16846526","citation_count":46,"is_preprint":false},{"pmid":"30232425","id":"PMC_30232425","title":"The role of CD32 during HIV-1 infection.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/30232425","citation_count":44,"is_preprint":false},{"pmid":"8695800","id":"PMC_8695800","title":"Characterization of Grb2-binding proteins in human platelets activated by Fc gamma RIIA cross-linking.","date":"1996","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8695800","citation_count":44,"is_preprint":false},{"pmid":"19494328","id":"PMC_19494328","title":"Association of FcgammaRIIa (CD32a) with lipid rafts regulates ligand binding activity.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19494328","citation_count":43,"is_preprint":false},{"pmid":"10201955","id":"PMC_10201955","title":"Ligation of Fc gamma RII (CD32) pivotally regulates survival of human eosinophils.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10201955","citation_count":43,"is_preprint":false},{"pmid":"8323742","id":"PMC_8323742","title":"Tissue distribution of human IgG Fc receptors CD16, CD32 and CD64: an immunohistochemical study.","date":"1993","source":"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/8323742","citation_count":42,"is_preprint":false},{"pmid":"35739102","id":"PMC_35739102","title":"Pentraxin 3 regulated by miR-224-5p modulates macrophage reprogramming and exacerbates osteoarthritis associated synovitis by targeting CD32.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35739102","citation_count":42,"is_preprint":false},{"pmid":"25100508","id":"PMC_25100508","title":"FcγRIII (CD16)-mediated ADCC by NK cells is regulated by monocytes and FcγRII (CD32).","date":"2014","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25100508","citation_count":42,"is_preprint":false},{"pmid":"32658257","id":"PMC_32658257","title":"FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunity.","date":"2020","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32658257","citation_count":40,"is_preprint":false},{"pmid":"17244681","id":"PMC_17244681","title":"Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between Fc{gamma}RIIa and CXCR1/2.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17244681","citation_count":40,"is_preprint":false},{"pmid":"8772237","id":"PMC_8772237","title":"Role of Fc gamma RIIA gene polymorphism in human platelet activation by monoclonal antibodies.","date":"1995","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/8772237","citation_count":40,"is_preprint":false},{"pmid":"20007585","id":"PMC_20007585","title":"Dynamics of the interaction of human IgG subtype immune complexes with cells expressing R and H allelic forms of a low-affinity Fc gamma receptor CD32A.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20007585","citation_count":39,"is_preprint":false},{"pmid":"2532230","id":"PMC_2532230","title":"Human basophils selectively express the Fc gamma RII (CDw32) subtype of IgG receptor.","date":"1989","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2532230","citation_count":38,"is_preprint":false},{"pmid":"29780387","id":"PMC_29780387","title":"CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29780387","citation_count":36,"is_preprint":false},{"pmid":"32075737","id":"PMC_32075737","title":"CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32075737","citation_count":35,"is_preprint":false},{"pmid":"25848939","id":"PMC_25848939","title":"Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25848939","citation_count":35,"is_preprint":false},{"pmid":"12676989","id":"PMC_12676989","title":"Signal sequence within Fc gamma RIIA controls calcium wave propagation patterns: apparent role in phagolysosome fusion.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12676989","citation_count":34,"is_preprint":false},{"pmid":"8496609","id":"PMC_8496609","title":"Expression of the Fc receptor for IgG (Fc gamma RII/CDw32) by human circulating T and B lymphocytes.","date":"1993","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8496609","citation_count":34,"is_preprint":false},{"pmid":"31479522","id":"PMC_31479522","title":"In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab.","date":"2019","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31479522","citation_count":34,"is_preprint":false},{"pmid":"25093412","id":"PMC_25093412","title":"A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25093412","citation_count":33,"is_preprint":false},{"pmid":"17710620","id":"PMC_17710620","title":"Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients.","date":"2007","source":"Medical mycology","url":"https://pubmed.ncbi.nlm.nih.gov/17710620","citation_count":33,"is_preprint":false},{"pmid":"29233917","id":"PMC_29233917","title":"C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis.","date":"2017","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/29233917","citation_count":31,"is_preprint":false},{"pmid":"31249568","id":"PMC_31249568","title":"FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31249568","citation_count":30,"is_preprint":false},{"pmid":"28000949","id":"PMC_28000949","title":"IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation.","date":"2017","source":"Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28000949","citation_count":30,"is_preprint":false},{"pmid":"10397151","id":"PMC_10397151","title":"Biochemical analysis and crystallisation of Fc gamma RIIa, the low affinity receptor for IgG.","date":"1999","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/10397151","citation_count":30,"is_preprint":false},{"pmid":"28886140","id":"PMC_28886140","title":"Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28886140","citation_count":29,"is_preprint":false},{"pmid":"27074847","id":"PMC_27074847","title":"Associations between PTPRC rs10919563 A/G and FCGR2A R131H polymorphisms and responsiveness to TNF blockers in rheumatoid arthritis: a meta-analysis.","date":"2016","source":"Rheumatology international","url":"https://pubmed.ncbi.nlm.nih.gov/27074847","citation_count":28,"is_preprint":false},{"pmid":"15130090","id":"PMC_15130090","title":"Recruitment of the cross-linked opsonic receptor CD32A (FcgammaRIIA) to high-density detergent-resistant membrane domains in human neutrophils.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15130090","citation_count":28,"is_preprint":false},{"pmid":"19284648","id":"PMC_19284648","title":"FcgammaRIIa (CD32) polymorphism and anti-malarial IgG subclass pattern among Fulani and sympatric ethnic groups living in eastern Sudan.","date":"2009","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/19284648","citation_count":28,"is_preprint":false},{"pmid":"9763567","id":"PMC_9763567","title":"A regulatory role for Fcgamma receptors CD16 and CD32 in the development of murine B cells.","date":"1998","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9763567","citation_count":28,"is_preprint":false},{"pmid":"17081622","id":"PMC_17081622","title":"Anti-OxLDL IgG blocks OxLDL interaction with CD36, but promotes FcgammaR, CD32A-dependent inflammatory cell adhesion.","date":"2006","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/17081622","citation_count":27,"is_preprint":false},{"pmid":"8566068","id":"PMC_8566068","title":"The beta 2 integrin Mac-1 but not p150,95 associates with Fc gamma RIIA.","date":"1996","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8566068","citation_count":27,"is_preprint":false},{"pmid":"22467926","id":"PMC_22467926","title":"FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-α blockers in psoriatic arthritis: a longitudinal study with 6 months of followup.","date":"2012","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/22467926","citation_count":27,"is_preprint":false},{"pmid":"19640933","id":"PMC_19640933","title":"FCGR2B gene polymorphism rather than FCGR2A, FCGR3A and FCGR3B is associated with anti-GBM disease in Chinese.","date":"2009","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/19640933","citation_count":26,"is_preprint":false},{"pmid":"33101269","id":"PMC_33101269","title":"Human Liver Macrophage Subsets Defined by CD32.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33101269","citation_count":26,"is_preprint":false},{"pmid":"20439102","id":"PMC_20439102","title":"Analysis of MIF, FCGR2A and FCGR3A gene polymorphisms with susceptibility to pulmonary tuberculosis in Moroccan population.","date":"2010","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/20439102","citation_count":26,"is_preprint":false},{"pmid":"11223444","id":"PMC_11223444","title":"Levels of expression of Fcgamma receptor IIA (CD32) are decreased on peripheral blood monocytes in patients with severe atherosclerosis.","date":"2001","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/11223444","citation_count":26,"is_preprint":false},{"pmid":"9242561","id":"PMC_9242561","title":"Fc gammaRII (CD32) is linked to apoptotic pathways in murine granulocyte precursors and mature eosinophils.","date":"1997","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9242561","citation_count":26,"is_preprint":false},{"pmid":"26490967","id":"PMC_26490967","title":"Fc Gamma Receptor IIA (CD32A) R131 Polymorphism as a Marker of Genetic Susceptibility to Sepsis.","date":"2016","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/26490967","citation_count":26,"is_preprint":false},{"pmid":"18022136","id":"PMC_18022136","title":"Interethnic differences in carriage of haemoglobin AS and Fcgamma receptor IIa (CD32) genotypes in children living in eastern Sudan.","date":"2007","source":"Acta tropica","url":"https://pubmed.ncbi.nlm.nih.gov/18022136","citation_count":25,"is_preprint":false},{"pmid":"11719384","id":"PMC_11719384","title":"The cytoplasmic domain of FcgammaRIIA (CD32) participates in phagolysosome formation.","date":"2001","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11719384","citation_count":25,"is_preprint":false},{"pmid":"10233903","id":"PMC_10233903","title":"Monoclonal Lym-1 antibody-dependent cytolysis by neutrophils exposed to granulocyte-macrophage colony-stimulating factor: intervention of FcgammaRII (CD32), CD11b-CD18 integrins, and CD66b glycoproteins.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10233903","citation_count":25,"is_preprint":false},{"pmid":"16551965","id":"PMC_16551965","title":"Neutrophil responsiveness to IgG, as determined by fixed ratios of mRNA levels for activating and inhibitory FcgammaRII (CD32), is stable over time and unaffected by cytokines.","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16551965","citation_count":24,"is_preprint":false},{"pmid":"15004265","id":"PMC_15004265","title":"Fc gamma RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patients.","date":"2004","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/15004265","citation_count":24,"is_preprint":false},{"pmid":"21934067","id":"PMC_21934067","title":"C-reactive protein-derived peptide 201-206 inhibits neutrophil adhesion to endothelial cells and platelets through CD32.","date":"2011","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/21934067","citation_count":23,"is_preprint":false},{"pmid":"7515918","id":"PMC_7515918","title":"CD31 (PECAM-1), CDw32 (Fc gamma RII), and anti-HLA class I monoclonal antibodies recognize phosphotyrosine-containing proteins on the surface of human neutrophils.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7515918","citation_count":23,"is_preprint":false},{"pmid":"27270653","id":"PMC_27270653","title":"Association of FCGR2A rs1801274 polymorphism with susceptibility to autoimmune diseases: A meta-analysis.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27270653","citation_count":22,"is_preprint":false},{"pmid":"7543071","id":"PMC_7543071","title":"Granulocyte colony-stimulating factor (G-CSF) administration increases PMN CD32 (FcRII) expression and FcR-related functions.","date":"1995","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/7543071","citation_count":22,"is_preprint":false},{"pmid":"18565176","id":"PMC_18565176","title":"Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro.","date":"2008","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/18565176","citation_count":22,"is_preprint":false},{"pmid":"26314337","id":"PMC_26314337","title":"FCGR2A, FCGR3A, FCGR3B polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.","date":"2015","source":"Clinical and experimental rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/26314337","citation_count":21,"is_preprint":false},{"pmid":"21780194","id":"PMC_21780194","title":"E-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population.","date":"2011","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/21780194","citation_count":21,"is_preprint":false},{"pmid":"31884867","id":"PMC_31884867","title":"Association of TNF-α rs1800629, CASP3 rs72689236 and FCGR2A rs1801274 Polymorphisms with Susceptibility to Kawasaki Disease: A Comprehensive Meta-Analysis.","date":"2019","source":"Fetal and pediatric pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31884867","citation_count":20,"is_preprint":false},{"pmid":"37029410","id":"PMC_37029410","title":"Modeling of clinical phenotypes in systemic lupus erythematosus based on the platelet transcriptome and FCGR2a genotype.","date":"2023","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37029410","citation_count":20,"is_preprint":false},{"pmid":"19243842","id":"PMC_19243842","title":"Age related variation in expression of CD21 and CD32 on bovine lymphocytes: a cross-sectional study.","date":"2009","source":"Veterinary immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/19243842","citation_count":20,"is_preprint":false},{"pmid":"31239514","id":"PMC_31239514","title":"CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype.","date":"2019","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31239514","citation_count":20,"is_preprint":false},{"pmid":"21208440","id":"PMC_21208440","title":"Polymorphisms of CD16A and CD32 Fcγ receptors and circulating immune complexes in Ménière's disease: a case-control study.","date":"2011","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21208440","citation_count":20,"is_preprint":false},{"pmid":"22906996","id":"PMC_22906996","title":"ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy.","date":"2012","source":"Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22906996","citation_count":19,"is_preprint":false},{"pmid":"35149195","id":"PMC_35149195","title":"The FCGR2A rs1801274 polymorphism was associated with the risk of death among COVID-19 patients.","date":"2022","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/35149195","citation_count":19,"is_preprint":false},{"pmid":"26089602","id":"PMC_26089602","title":"FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease.","date":"2015","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/26089602","citation_count":18,"is_preprint":false},{"pmid":"11254726","id":"PMC_11254726","title":"Evidence for a role for SAM68 in the responses of human neutrophils to ligation of CD32 and to monosodium urate crystals.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11254726","citation_count":18,"is_preprint":false},{"pmid":"15188132","id":"PMC_15188132","title":"The role of beta-catenin, TGF beta 3, NGF2, FGF2, IGFR2, and BMP4 in the pathogenesis of mesenteric sclerosis and angiopathy in midgut carcinoids.","date":"2004","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/15188132","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":55685,"output_tokens":8754,"usd":0.149182},"stage2":{"model":"claude-opus-4-6","input_tokens":12879,"output_tokens":3927,"usd":0.243855},"total_usd":0.393037,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"FCGR2A (FcγRIIa/CD32A) encodes an integral membrane glycoprotein with two extracellular Ig-like domains, a single transmembrane domain, and a cytoplasmic domain distinct from FcγRIIb isoforms; expression of the cDNA in transfected cells produces IgG-binding molecules bearing CD32 epitopes, establishing it as a functional IgG receptor.\",\n      \"method\": \"cDNA cloning, sequencing, and transfection expression assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original structural/functional characterization by reconstitution in transfected cells, foundational paper\",\n      \"pmids\": [\"2529342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The IgG Fc binding site of FcγRII (CD32) maps primarily to the second extracellular domain (D2γ), with epitopes defined by blocking mAbs all residing in D2γ and involving the IgG Fc binding region; domain 1 contributes to overall binding affinity.\",\n      \"method\": \"Chimeric receptor construction, mAb epitope mapping, EA rosette inhibition assays, flow cytometry on transfected cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods including chimeric receptors and functional blocking assays\",\n      \"pmids\": [\"7679695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"FcγRIIa (CD32A) is the sole IgG Fc receptor capable of binding human IgG2; the H131 allotype binds IgG2 with significantly higher affinity than the R131 allotype, and neutrophils homozygous for H/H131 mediate significantly greater phagocytosis of IgG2-opsonized bacteria than R/R131 neutrophils.\",\n      \"method\": \"Immunophenotyping, phagocytosis assays with IgG2-opsonized bacteria in neutrophils from genotyped donors\",\n      \"journal\": \"The Journal of infectious diseases\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional phagocytosis assay directly linking allotype to IgG2 binding and bacterial killing, replicated across studies\",\n      \"pmids\": [\"7930727\", \"7930726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The H131/R131 polymorphism at amino acid 131 of FcγRIIa is determined by a single nucleotide difference (G or A) at base 494 encoding arginine or histidine, which dictates differential affinity for human IgG2.\",\n      \"method\": \"PCR amplification of genomic DNA and Southern analysis with allele-specific oligonucleotide probes\",\n      \"journal\": \"Journal of immunological methods\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct genotyping method establishing molecular basis of the polymorphism\",\n      \"pmids\": [\"8046255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"FcγRIIa (CD32A) cross-linking on B lymphocytes triggers increases in intracellular Ca2+ ([Ca2+]i), whereas FcγRIIb isoforms do not; FcγRIIa efficiently internalizes IgG aggregates while FcγRIIb1 does not, demonstrating isoform-specific functional differences.\",\n      \"method\": \"Stable transfection of isoforms into mouse IIA1.6 B lymphoma cells, Ca2+ flux measurements, internalization assays, receptor capping assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in defined cell system with multiple functional readouts\",\n      \"pmids\": [\"8283039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Multiple regions of FcγRII contribute to IgG binding: domain 1 contributes to affinity, and two segments of domain 2 (Ser109–Val116 and Ser130–Thr135, including residues Lys113, Pro114, Leu115, Val116, Phe129, and His131) are critical for IgG1 binding; substitution of Asp133 and Pro134 increases binding.\",\n      \"method\": \"Chimeric receptor construction between FcγRII and FcεRIα, site-directed mutagenesis, IgG binding assays, molecular modeling\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — chimeric receptor and site-directed mutagenesis with functional binding readout\",\n      \"pmids\": [\"7673151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"FcγRIIa signaling following cross-linking requires activation of Src-family tyrosine kinases and Syk, resulting in tyrosine phosphorylation of Shc and phospholipase Cγ isoforms and a cytosolic Ca2+ transient.\",\n      \"method\": \"Biochemical signaling assays, kinase inhibitor studies, immunoprecipitation\",\n      \"journal\": \"Seminars in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — review summarizing direct experimental findings from signaling studies, single source\",\n      \"pmids\": [\"7612894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The H131/R131 polymorphism at position 131 of FcγRIIa modulates binding of monoclonal IgG1 antibodies on platelets; the R131 form binds IgG1 mAbs with stronger affinity than H131, and differential platelet activation by mAbs correlates with the allotype-dependent binding affinity.\",\n      \"method\": \"Allotype-specific genotyping, IgG mAb binding assays on platelets from homozygous/heterozygous donors, platelet aggregation measurements\",\n      \"journal\": \"Thrombosis and haemostasis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding and functional assays in human platelets with defined genotypes\",\n      \"pmids\": [\"8772237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"FcγRIIa (CD32A) cross-linking on dermal microvascular endothelial cells (DMEC) triggers immediate intracellular Ca2+ flux and rapid receptor internalization, demonstrating functional signaling capacity; DMEC express FcγRIIa (not FcγRIIb or FcγRIII) as determined by RT-PCR.\",\n      \"method\": \"Immunohistochemistry, RT-PCR, FACS, intracellular Ca2+ measurement, receptor internalization assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional assays with isoform-specific confirmation by RT-PCR\",\n      \"pmids\": [\"8568259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"FcγRIIa cross-linking in platelets leads to tyrosine phosphorylation and recruitment of Grb2-binding proteins (38 kDa and 63 kDa) in the particulate fraction; SH3 domains of Grb2 associate with SOS1, SLP-76 (75 kDa), and a 120 kDa protein, linking FcγRIIa to downstream Ras/SOS signaling.\",\n      \"method\": \"GST-Grb2 fusion protein pulldown, immunoprecipitation, SH2/SH3 domain binding assays, phosphoprotein identification by immunoblot\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-precipitation and domain-specific pulldown identifying signaling complex components\",\n      \"pmids\": [\"8695800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Mac-1 (CD11b/CD18, αMβ2 integrin) but not p150,95 (CD11c/CD18) associates with FcγRIIA on K562 cells; anti-FcγRII mAbs inhibit Mac-1-mediated cell adhesion but not p150,95-mediated adhesion.\",\n      \"method\": \"Transfection of K562 cells with Mac-1 or p150,95, adhesion inhibition assays with anti-FcγRII mAbs\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional association demonstrated by mAb inhibition without direct co-immunoprecipitation\",\n      \"pmids\": [\"8566068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"FcγRIIc (CD32) expression on NK cells is determined by an allelic polymorphism in the FcγRIIC gene first extracellular exon that generates either a functional open reading frame or a null allele; donors with the functional allele express CD32 capable of triggering NK-cell cytotoxicity, while null allele donors lack surface CD32 on NK cells.\",\n      \"method\": \"cDNA isolation and sequencing from NK cells, stable transfection, flow cytometry, cytotoxicity assays correlated with allele presence\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods including transfection and functional cytotoxicity assay\",\n      \"pmids\": [\"9516136\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"FcγRIIa ligation on eosinophils in solution (soluble anti-CD32 mAb or cross-linked IgG) promotes survival by inducing autocrine GM-CSF production, whereas immobilized anti-CD32 mAb or IgG triggers eosinophil apoptosis dependent on β2 integrin engagement.\",\n      \"method\": \"In vitro eosinophil culture with anti-CD32 mAbs in solution vs. immobilized, apoptosis detection (DNA fragmentation, Annexin-V), anti-GM-CSF blocking, anti-CD18 blocking\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic dissection with blocking antibodies and multiple readouts\",\n      \"pmids\": [\"10201955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Biochemical characterization established that FcγRIIa binds IgG3 (KD = 0.6 μM) and also IgG4 (KD = 3 μM), extending its known ligand repertoire; both N-linked glycosylation sites on FcγRIIa are occupied.\",\n      \"method\": \"Equilibrium binding analysis of recombinant FcγRIIa with IgG subclasses, electrospray ionization mass spectrometry for glycan characterization, crystallization yielding diffraction-quality crystals at 2.1 Å\",\n      \"journal\": \"Immunology letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro binding assay with recombinant protein and structural crystallization\",\n      \"pmids\": [\"10397151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"In resting neutrophils, FcγRIIa (CD32A) is maintained in a low-affinity state for IgG binding; activation with fMLP converts CD32A to a high-affinity state without increasing surface expression, enabling CD32A-dependent immune complex binding and phagocytosis. This affinity modulation was not observed in CHO cells expressing CD32A, indicating a cell-specific mechanism.\",\n      \"method\": \"Use of CD16B-deficient donor neutrophils and anti-CD16 blocking mAbs, fMLP activation, IgG-opsonized erythrocyte rosetting assays, immune complex binding assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — natural genetic deficiency model combined with activation assays and CHO cell controls demonstrating cell-specificity\",\n      \"pmids\": [\"10648424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CD32 cross-linking in platelets rapidly induces tyrosine phosphorylation and activation of Bruton's tyrosine kinase (Btk) and Tec kinase via a mechanism involving Src family kinases and PI3K through ITAM-mediated recruitment.\",\n      \"method\": \"CD32 cross-linking in human platelets (including XLA patient platelets), immunoprecipitation, phosphopeptide-specific antibodies against Btk regulatory residues, kinase inhibitor studies\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical and pharmacological dissection of kinase activation downstream of CD32\",\n      \"pmids\": [\"10688822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The cytoplasmic tail of FcγRIIa is required for phagolysosome fusion: wild-type FcγRIIa-mediated phagosomes fuse with lysosomes, but a tail-minus FcγRIIa (even when phagocytosis is rescued by complement receptor CR3) fails to support phagolysosome fusion. This function does not require a functional ITAM sequence.\",\n      \"method\": \"Genetic complementation using tail-minus and ITAM-mutant FcγRIIa, fluorescent dextran lysosome labeling, colocalization microscopy, electron microscopy with acid phosphatase detection\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with reconstitution and multiple imaging methods establishing cytoplasmic tail requirement for a specific downstream function\",\n      \"pmids\": [\"11719384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"SAM68 (68 kDa Src-associated protein) is present in human neutrophils, becomes tyrosine-phosphorylated following CD32 ligation, and its association with poly-U RNA decreases upon CD32 stimulation, implicating SAM68 in post-transcriptional regulation downstream of FcγRIIa.\",\n      \"method\": \"Immunoprecipitation, tyrosine phosphorylation assays, poly-U Sepharose pulldown assays after CD32 cross-linking\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single method type, mechanistic follow-up partial\",\n      \"pmids\": [\"11254726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Cross-linking of FcγRII (CD32) with immobilized IgG induces maturation of human monocyte-derived dendritic cells via the NF-κB signaling pathway, accompanied by moderate IL-10 (but not IL-12) secretion and enhanced allogeneic T cell proliferation; this is blocked by anti-CD32 mAb.\",\n      \"method\": \"Cross-linking with immobilized IgG, NF-κB activation assays, cytokine ELISA, allogeneic T cell proliferation assay, anti-CD32 mAb blocking\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor-specific blocking with defined pathway readout\",\n      \"pmids\": [\"12682223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The cytoplasmic L-T-L motif of FcγRIIa controls the spatiotemporal routing of calcium waves to phagosomes: mutation of this motif prevents calcium signal routing to the phagosome and abrogates phagolysosome fusion, despite normal recruitment of lysosome-associated proteins Rab5 and Rab7.\",\n      \"method\": \"High-speed calcium imaging of live cells, mutagenesis of cytoplasmic L-T-L motif, immunofluorescence for Rab5, Rab7, and LAMP-1\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — site-directed mutagenesis with live-cell functional imaging and multiple controls identifying specific cytoplasmic sequence\",\n      \"pmids\": [\"12676989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Cross-linking of CD32A in neutrophil plasma membranes causes its recruitment to high-density flotillin-1-positive detergent-resistant membrane (DRM) microdomains prior to tyrosine phosphorylation; Src kinases and Syk are constitutively present in DRMs and tyrosine phosphorylation of CD32A and Syk is inhibited by the Src kinase inhibitor PP2 and by methyl-β-cyclodextrin.\",\n      \"method\": \"Purified neutrophil plasma membranes, DRM fractionation, immunoblotting, Src kinase inhibitor PP2, methyl-β-cyclodextrin cholesterol depletion\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical fractionation with pharmacological inhibitors in defined membrane system\",\n      \"pmids\": [\"15130090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DNA-containing immune complexes from lupus serum activate plasmacytoid DCs via cooperative interaction between FcγRIIa (CD32) and TLR9: CD32 internalizes SLE immune complexes into a subcellular compartment co-containing TLR9, and only CD32+ PDCs (not CD32- PDCs) respond to SLE-ICs, defining a pathway where CD32 delivers immune complexes to lysosomal TLR9.\",\n      \"method\": \"Colocalization microscopy, sorting of CD32+ vs CD32- PDCs, cytokine/chemokine production assays, blocking with anti-CD32\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including sorting, colocalization, and functional cytokine assays, highly cited\",\n      \"pmids\": [\"15668740\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"FcγRIIA (CD32) mediates enhanced dengue virus immune complex infectivity more effectively than FcγRIA; abrogation of FcγRIIA ITAM signaling by tyrosine-to-phenylalanine mutagenesis impairs phagocytosis equally but does not impair dengue virus immune complex infectivity, revealing a signaling-independent mechanism of viral internalization via FcγRIIA.\",\n      \"method\": \"Site-directed mutagenesis of ITAM tyrosines, transfection into COS-7 cells, dengue virus replication assays (plaque assay and flow cytometry)\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with reconstitution in defined cell system distinguishing phagocytosis from viral entry\",\n      \"pmids\": [\"17005690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Antiendothelial cell antibodies (AECAs) bound to endothelial cells enhance PMN adhesion through FcγRIIa in an E-selectin-, CXCR1/2-, and β2-integrin-dependent mechanism requiring cooperation between FcγRIIa and CXCR1/2; this mechanism is distinct from immune complex-mediated FcγRIIIb-dependent PMN adhesion.\",\n      \"method\": \"Adenoviral transduction of endothelial cells, neutralizing antibodies to E-selectin/CXCR1/2/β2-integrins, anti-FcγRIIa blocking, pertussis toxin inhibition, AECA IgG from SLE patients\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple blocking antibodies and genetic approaches defining cooperative mechanism with distinct pathway readout\",\n      \"pmids\": [\"17244681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CD300a (IRp60), an ITIM-containing inhibitory receptor, colligates with FcγRIIa (CD32A) on neutrophils to inhibit CD32A-mediated signaling but not TLR4-mediated ROS production, demonstrating selective inhibitory control of FcγRIIa-dependent responses.\",\n      \"method\": \"Co-ligation experiments with anti-CD300a and anti-CD32A in neutrophils, ROS production assays, signaling inhibition assays\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-ligation functional assay with specificity control (TLR4 not affected)\",\n      \"pmids\": [\"17588661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Bevacizumab immune complexes (with VEGF) activate platelets via FcγRIIa and cause thrombosis in FcγRIIa transgenic mice; VEGF's heparin-binding domain is required, and heparin promotes Bev IC deposition on platelets in a mechanism resembling heparin-induced thrombocytopenia.\",\n      \"method\": \"In vitro platelet activation assays, FcγRIIa transgenic mice thrombosis model, aglycosylated antibody controls, heparin-binding domain analysis\",\n      \"journal\": \"Journal of thrombosis and haemostasis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo assays with mechanistic controls including aglycosylated antibody and domain-specific requirements\",\n      \"pmids\": [\"18983497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"IVIg and CMVIg induce CD32-dependent platelet aggregation in vitro; the aggregation is completely abrogated by an anti-CD32 blocking antibody (AT10), demonstrating that activating Fc domains in immunoglobulin preparations directly engage platelet FcγRIIa to trigger aggregation.\",\n      \"method\": \"In vitro aggregometry with platelet concentrates, anti-CD32 mAb (AT10) blocking, CD62P expression by FACS, sCD40L ELISA\",\n      \"journal\": \"The British journal of dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor-specific blocking with multiple platelet activation readouts\",\n      \"pmids\": [\"18565176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"FcγRIIa (CD32A) association with lipid raft microdomains regulates its IgG binding activity: cholesterol depletion or sequestration inhibits CD32A-mediated IgG binding; CD32A mutants with reduced lipid raft association (A224S and C241A) show decreased IgG binding; GPI-anchored (constitutively raft-associated) CD32A displays increased IgG binding capacity.\",\n      \"method\": \"Cholesterol depletion/sequestration, site-directed mutagenesis of CD32A (A224S, C241A), GPI-anchored CD32A construct, IgG binding assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with pharmacological manipulation and GPI-anchor reconstitution with functional binding readout\",\n      \"pmids\": [\"19494328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The R allele of CD32A has significantly lower binding affinity not only to IgG2 but also to IgG1 and IgG3 compared with the H allele; CD32A(H)-Ig outcompetes CD32A(R)-Ig for immune complex binding, whereas CD32A(R)-Ig cannot cross-block CD32A(H) binding, as shown by 2D affinity measurements.\",\n      \"method\": \"Ig fusion proteins of CD32A alleles, competition binding assays, 2D affinity measurements, cell surface CD32A blocking studies\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro binding assays with purified allelic proteins and 2D affinity measurements\",\n      \"pmids\": [\"20007585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Anti-CD40L immune complex-induced thrombosis is FcγRIIa-dependent: anti-CD40L ICs cause shock, thrombocytopenia, and pulmonary thrombi in FCGR2A transgenic mice but not wild-type mice; aglycosylated antibody (which cannot bind FcγRIIa) fails to cause these effects.\",\n      \"method\": \"FCGR2A transgenic mouse model, i.v. injection of preformed ICs, aglycosylated antibody control, thrombin inhibitor pretreatment, histopathology of pulmonary thrombi\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic model with aglycosylated antibody control establishing FcγRIIa requirement\",\n      \"pmids\": [\"20585032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CRP-derived peptide 201–206 inhibits neutrophil adhesion to endothelial cells and platelet-mediated neutrophil capture via CD32 (FcγRII); anti-CD32 but not anti-CD16 or anti-CD64 mAb blocks these inhibitory actions; specific residues Lys201, Gln203, and Trp205 are required for peptide-CD32 interaction.\",\n      \"method\": \"Anti-CD32/CD16/CD64 mAb blocking of peptide effects, alanine-substitution peptide analogues, neutrophil adhesion under shear flow, platelet P-selectin assays\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor-specific blocking and structure-activity analysis identifying key residues\",\n      \"pmids\": [\"21934067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CRP binds surface CD32 (FcγRII) on myeloma cells and activates a p38 MAPK–Twist signaling pathway that enhances secretion of osteolytic cytokines and promotes osteoclastogenesis and bone destruction in vivo.\",\n      \"method\": \"CRP-CD32 binding assays, p38 MAPK activation and Twist pathway analysis, in vivo human bone graft/myeloma xenograft model, cytokine secretion assays\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro pathway analysis and in vivo model establishing ligand-receptor-pathway-phenotype link\",\n      \"pmids\": [\"29233917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"FcγRIIA/CD32A-expressing platelets are directly activated by IgG immune complexes in vivo and are critical determinants of IgG-dependent anaphylaxis severity: platelet depletion attenuates anaphylaxis, thrombocythemia worsens it, and serotonin released by activated platelets contributes to severity. FcγRIIA-expressing platelets are sufficient to restore anaphylaxis susceptibility in resistant mice.\",\n      \"method\": \"Human FcγRIIA-expressing mouse models, platelet depletion, thrombocythemia induction, platelet activation by IgG ICs in vivo, serotonin blockade, patient cohort correlation\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vivo genetic models with sufficiency/necessity testing and mechanistic mediator identification\",\n      \"pmids\": [\"29654057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BTK is a key downstream mediator of FcγRIIA (CD32a)-induced platelet activation; BTK inhibitors (ibrutinib, acalabrutinib, zanubrutinib, tirabrutinib, evobrutinib, fenebrutinib) potently block FcγRIIA cross-linking-induced platelet aggregation, secretion, P-selectin expression, and platelet-neutrophil complex formation at clinically relevant concentrations.\",\n      \"method\": \"FcγRIIA cross-linking in human blood, aggregometry with BTK inhibitors at defined IC50 values, P-selectin FACS, ATP secretion assays, HIT patient sera stimulation, single oral dose pharmacodynamics in volunteers\",\n      \"journal\": \"Blood advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple BTK inhibitors with consistent IC50 values, multiple platelet activation readouts, and ex vivo clinical validation\",\n      \"pmids\": [\"31809536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"FcRn acts as a coreceptor for CD32a (FcγRIIa): CD32aH (H131 variant) more avidly binds human IgG1 immune complexes than CD32aR and forms a ternary complex with FcRn under acidic conditions; both CD32a variants require FcRn to induce innate and adaptive immune responses to IgG1 ICs, with responses augmented for CD32aH. FcRn blockade reduced inflammation in an arthritis model without lowering circulating autoantibody levels.\",\n      \"method\": \"Binding assays (CD32aH vs CD32aR with IgG1 IC), ternary complex formation assays under acidic pH, primary human and mouse cell functional assays, FcRn knockout/blockade, rheumatoid arthritis model\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including biochemical complex formation, primary cell assays, in vivo model with genetic and pharmacological FcRn manipulation\",\n      \"pmids\": [\"32658257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SRF231, a human IgG4 anti-CD47 antibody, exerts antitumor activity via dual engagement of macrophage-derived CD32a: its Fc domain engages CD32a to drive FcγR-mediated phagocytosis of cancer cells and acts as a scaffold to drive CD47-mediated death signaling into tumor cells; both mechanisms are CD32a-dependent.\",\n      \"method\": \"In vitro macrophage:tumor cell co-culture, FcγR blocking, macrophage depletion, xenograft mouse models, cytokine analysis\",\n      \"journal\": \"Journal for immunotherapy of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor-specific blocking and macrophage depletion with mechanistic dissection in vitro and in vivo\",\n      \"pmids\": [\"32345627\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FcγRIIa (FCGR2A/CD32A) is a single-transmembrane activating IgG Fc receptor whose second extracellular domain (particularly residues around His131) mediates IgG binding with allotype-dependent affinity (H131 > R131 for IgG1/2/3), whose ITAM-containing cytoplasmic tail recruits Src-family kinases and Syk to trigger Ca2+ flux, Btk/Tec activation, and downstream signaling; association with lipid rafts regulates its IgG-binding affinity, while an L-T-L cytoplasmic motif routes Ca2+ signals to phagosomes enabling phagolysosome fusion; on platelets and myeloid cells FcγRIIa transduces IgG immune complex signals through Syk and BTK to mediate phagocytosis, ADCC, anaphylaxis, and thrombosis, and cooperates with FcRn as a coreceptor and with TLR9 (via immune complex internalization) and with inhibitory receptors such as CD300a and FcγRIIb to fine-tune immune activation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FCGR2A (Fc\\u03b3RIIa/CD32A) is a low-affinity activating IgG Fc receptor expressed on myeloid cells, platelets, and endothelial cells that transduces immune complex signals to drive phagocytosis, platelet activation, dendritic cell maturation, and anaphylaxis. Its two extracellular Ig-like domains bind all four human IgG subclasses, with the second domain (D2) harboring critical contact residues including the H131/R131 polymorphism that governs allotype-dependent affinity — the H131 variant uniquely confers efficient IgG2 binding and generally higher affinity for IgG1 and IgG3 [PMID:7930727, PMID:20007585]. Cross-linking triggers ITAM-dependent recruitment of Src-family kinases and Syk, activation of Btk/Tec kinases, PLC\\u03b3 phosphorylation, and Ca²⁺ flux, while lipid-raft association regulates IgG-binding capacity and a cytoplasmic L-T-L motif routes calcium signals to phagosomes to enable phagolysosome fusion [PMID:7612894, PMID:19494328, PMID:12676989, PMID:31809536]. Beyond classical ITAM signaling, Fc\\u03b3RIIa cooperates with FcRn as a coreceptor for IgG1 immune complex responses, delivers DNA-containing immune complexes to TLR9 in plasmacytoid dendritic cells, and on platelets is the critical receptor mediating IgG immune complex–driven thrombosis and IgG-dependent anaphylaxis [PMID:32658257, PMID:15668740, PMID:29654057, PMID:20585032].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Molecular cloning established FCGR2A as a gene encoding a distinct activating IgG receptor isoform with two Ig-like extracellular domains, a transmembrane segment, and a unique cytoplasmic tail, resolving the molecular identity of the CD32A isoform.\",\n      \"evidence\": \"cDNA cloning, sequencing, and transfection expression in heterologous cells\",\n      \"pmids\": [\"2529342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full domain architecture and 3D structure not yet determined\", \"Signaling mechanism of cytoplasmic tail unknown\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Identification of the H131/R131 single-nucleotide polymorphism as the molecular basis for differential IgG subclass binding — particularly unique IgG2 recognition by the H131 variant — answered how genetic variation in a single receptor controls subclass-specific immunity and susceptibility to encapsulated bacterial infections.\",\n      \"evidence\": \"Genotyping by allele-specific oligonucleotides combined with phagocytosis assays of IgG2-opsonized bacteria in neutrophils from defined donors\",\n      \"pmids\": [\"7930727\", \"7930726\", \"8046255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of how position 131 alters IgG2 contact not resolved\", \"Clinical impact on infection outcomes required prospective studies\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Domain mapping and mutagenesis pinpointed the IgG-binding interface to two segments in extracellular domain 2 (Ser109–Val116 and Ser130–Thr135) while showing domain 1 contributes to overall affinity, defining the ligand-recognition architecture at residue-level resolution.\",\n      \"evidence\": \"Chimeric Fc\\u03b3RII/Fc\\u03b5RI\\u03b1 receptors, site-directed mutagenesis, and IgG binding assays\",\n      \"pmids\": [\"7673151\", \"7679695\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Co-crystal structure with IgG Fc not yet available\", \"Contribution of glycosylation to binding affinity unclear\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Biochemical dissection of the signaling cascade revealed that Fc\\u03b3RIIa cross-linking activates Src-family kinases and Syk, leading to PLC\\u03b3 phosphorylation, Shc recruitment, and Ca²⁺ flux — establishing the ITAM-dependent proximal signaling pathway distinct from the inhibitory Fc\\u03b3RIIb isoform.\",\n      \"evidence\": \"Kinase inhibitor studies, immunoprecipitation, Ca²⁺ measurements in transfected B cells and primary cells\",\n      \"pmids\": [\"7612894\", \"8283039\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of individual Src-family members not determined\", \"Signaling requirement for phagocytosis vs. other effector functions not separated\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Discovery that neutrophil activation (fMLP) converts surface Fc\\u03b3RIIa from a low- to high-affinity IgG-binding state without changing expression levels revealed an inside-out affinity regulation mechanism, explaining how resting cells avoid spurious immune complex engagement.\",\n      \"evidence\": \"IgG-opsonized erythrocyte rosetting with CD16B-deficient donor neutrophils vs. CHO cells expressing CD32A\",\n      \"pmids\": [\"10648424\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of affinity switch (conformational change, lateral partner, or lipid environment) not defined\", \"Whether affinity modulation operates in other cell types unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of the cytoplasmic L-T-L motif as the element routing Ca²⁺ signals to nascent phagosomes and enabling phagolysosome fusion — independent of the ITAM — resolved how Fc\\u03b3RIIa couples ligand engagement to microbicidal phagosome maturation beyond simple internalization.\",\n      \"evidence\": \"Site-directed mutagenesis of L-T-L motif, high-speed Ca²⁺ imaging, lysosomal colocalization microscopy\",\n      \"pmids\": [\"12676989\", \"11719384\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding partner of the L-T-L motif not identified\", \"Whether L-T-L motif regulates Ca²⁺ channel recruitment or release from stores unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstration that Fc\\u03b3RIIa internalizes DNA-containing immune complexes into TLR9-positive endosomal compartments of plasmacytoid dendritic cells established a cooperative Fc\\u03b3RIIa–TLR9 pathway linking adaptive IgG responses to innate nucleic acid sensing, with direct relevance to lupus pathogenesis.\",\n      \"evidence\": \"Sorting of CD32+ vs. CD32− PDCs, colocalization microscopy, anti-CD32 blocking, cytokine production assays\",\n      \"pmids\": [\"15668740\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other Fc\\u03b3Rs can substitute for CD32A in this pathway not tested\", \"Mechanism of immune complex routing to TLR9-containing compartment not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Mutagenesis and cholesterol manipulation showed that lipid-raft association regulates Fc\\u03b3RIIa IgG-binding capacity — with raft-excluded mutants binding less IgG and GPI-anchored (constitutively raft-associated) CD32A binding more — providing a membrane-organizational mechanism for affinity modulation.\",\n      \"evidence\": \"A224S and C241A mutants, GPI-anchored CD32A, cholesterol depletion/sequestration, IgG binding assays\",\n      \"pmids\": [\"19494328\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relationship between raft association and inside-out activation (fMLP effect) not integrated\", \"Whether raft partitioning changes receptor oligomerization state unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Quantitative 2D affinity measurements extended the allotype-dependent binding hierarchy to all tested IgG subclasses — H131 outcompetes R131 for IgG1, IgG2, and IgG3 — refining the functional impact of the polymorphism beyond the IgG2-centric view.\",\n      \"evidence\": \"Ig fusion proteins of both CD32A alleles, competition binding and 2D affinity assays\",\n      \"pmids\": [\"20007585\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Absolute 3D KD values for each allotype–subclass pair not all determined\", \"Functional consequences for IgG4 binding by each allotype not measured\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"In vivo demonstration that Fc\\u03b3RIIa on platelets is necessary and sufficient for immune complex–induced thrombosis — using transgenic mice, aglycosylated antibody controls, and thrombin inhibition — established the receptor as the key mediator of antibody-triggered thrombotic events such as heparin-induced thrombocytopenia.\",\n      \"evidence\": \"FCGR2A transgenic mouse thrombosis models with anti-CD40L and bevacizumab immune complexes, aglycosylated antibody controls\",\n      \"pmids\": [\"20585032\", \"18983497\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of platelet serotonin vs. thrombin generation not fully delineated\", \"Whether Fc\\u03b3RIIa signaling in thrombosis requires the same ITAM–Syk axis as phagocytosis not proven\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Fc\\u03b3RIIa-expressing platelets were shown to be critical determinants of IgG-dependent anaphylaxis severity in vivo: platelet depletion attenuated anaphylaxis, thrombocythemia exacerbated it, and serotonin released by activated platelets was identified as a key mediator, establishing a platelet–Fc\\u03b3RIIa–serotonin axis in systemic anaphylaxis.\",\n      \"evidence\": \"Human FCGR2A transgenic mice, platelet depletion/expansion, serotonin blockade, patient cohort correlation\",\n      \"pmids\": [\"29654057\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative importance of platelet vs. myeloid Fc\\u03b3RIIa in human anaphylaxis not resolved\", \"Downstream signaling from Fc\\u03b3RIIa to serotonin release machinery not mapped\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Pharmacological profiling with six distinct BTK inhibitors demonstrated that BTK is the critical kinase downstream of Fc\\u03b3RIIa cross-linking for platelet aggregation, secretion, and platelet–neutrophil complex formation, validating BTK as a druggable node in Fc\\u03b3RIIa-driven thromboinflammation.\",\n      \"evidence\": \"Multiple BTK inhibitors at defined IC50 values, aggregometry, P-selectin FACS, ATP secretion, HIT sera, single-dose pharmacodynamics in volunteers\",\n      \"pmids\": [\"31809536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether BTK inhibition also blocks Fc\\u03b3RIIa-driven phagocytosis in myeloid cells with equal potency not shown\", \"Compensatory kinase pathways in platelet Fc\\u03b3RIIa signaling not explored\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of FcRn as a coreceptor that forms a ternary complex with Fc\\u03b3RIIa and IgG1 immune complexes under acidic endosomal conditions revealed an unanticipated cooperative mechanism by which two Fc receptors jointly amplify innate and adaptive immune responses to IgG ICs.\",\n      \"evidence\": \"Biochemical ternary complex assays at acidic pH, FcRn knockout/blockade, primary human and mouse cell functional assays, arthritis model\",\n      \"pmids\": [\"32658257\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FcRn cooperates with Fc\\u03b3RIIa for all IgG subclasses not tested\", \"Structural basis of the ternary complex unknown\", \"Whether FcRn coreceptor function extends to Fc\\u03b3RIIa-mediated phagocytosis not demonstrated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of inside-out affinity regulation, the identity of the direct cytoplasmic binding partner of the L-T-L motif that routes Ca²⁺ to phagosomes, whether the FcRn–Fc\\u03b3RIIa coreceptor axis operates across all IgG subclasses and cell types, and how Fc\\u03b3RIIa signaling differentially programs cell-type-specific outcomes (phagocytosis, thrombosis, anaphylaxis, DC maturation).\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Structural basis of inside-out affinity modulation unknown\", \"L-T-L motif binding partner unidentified\", \"Cell-type-specific signaling wiring downstream of common ITAM not mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 4, 6, 15]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [24, 34]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 14, 20, 27]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [21, 34]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [16, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 4, 6, 18, 21, 32, 34]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 9, 15, 20, 31, 33]},\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [25, 26, 29, 32]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [12]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"SYK\",\n      \"BTK\",\n      \"TEC\",\n      \"FCGRT\",\n      \"TLR9\",\n      \"CD300A\",\n      \"ITGAM\",\n      \"KHDRBS1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}